p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells.

Por Rotter, V
Publicado em 1983

The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene.

Por Reisman, D, Rotter, V
Publicado em 1993

Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences.

Por Wolf, D, Rotter, V
Publicado em 1984

Induced expression from the Moloney murine leukemia virus long terminal repeat during differentiation of human myeloid cells is mediated through its transcriptional enhancer.

Por Reisman, D, Rotter, V
Publicado em 1989

Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

Por Wolf, D, Rotter, V
Publicado em 1985

Can an iPS cell secure its genomic fidelity?

Por Sarig, R, Rotter, V
Publicado em 2011

Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif.

Por Ronen, D, Rotter, V, Reisman, D
Publicado em 1991

Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.

Por Reisman, D, Greenberg, M, Rotter, V
Publicado em 1988

Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein.

Por Foord, O, Navot, N, Rotter, V
Publicado em 1993

Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ

Por Solomon, H, Sharon, M, Rotter, V
Publicado em 2014

Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents.

Por Rotter, V, Boss, M A, Baltimore, D
Publicado em 1981

In vitro expression of human p53 cDNA clones and characterization of the cloned human p53 gene.

Por Wolf, D, Laver-Rudich, Z, Rotter, V
Publicado em 1985

Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species.

Por Wolf, D, Admon, S, Oren, M, Rotter, V
Publicado em 1984

Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression.

Por Aloni-Grinstein, R, Schwartz, D, Rotter, V
Publicado em 1995

Involvement of wild-type p53 in pre-B-cell differentiation in vitro.

Por Shaulsky, G, Goldfinger, N, Peled, A, Rotter, V
Publicado em 1991

Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Por Ronen, D, Teitz, Y, Goldfinger, N, Rotter, V
Publicado em 1992

A DNA binding domain is contained in the C-terminus of wild type p53 protein.

Por Foord, O S, Bhattacharya, P, Reich, Z, Rotter, V
Publicado em 1991

Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.

Por Wolf, D, Harris, N, Goldfinger, N, Rotter, V
Publicado em 1985

P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibrobla...

Por Rotter, V, Abutbul, H, Ben-Ze'ev, A
Publicado em 1983

Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced form.

Por Wolkowicz, R, Peled, A, Elkind, N B, Rotter, V
Publicado em 1995